-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G3rhmoAZuHqXf+vLSPkGHUdzRNHSCsF3Ab9rb2FYVS68fAYVfYAwfim0QfxQtVvf l6OZY7XKwHlQMWJMxS1arw== 0000874015-09-000004.txt : 20090102 0000874015-09-000004.hdr.sgml : 20090101 20090102172806 ACCESSION NUMBER: 0000874015-09-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081230 FILED AS OF DATE: 20090102 DATE AS OF CHANGE: 20090102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARSHALL B LYNNE CENTRAL INDEX KEY: 0001073385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 09502121 BUSINESS ADDRESS: BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2008-12-30 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073385 PARSHALL B LYNNE C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 1 1 0 0 Director, COO Common Stock 2008-12-30 2008-12-30 4 M 0 5000 12.9375 A 9110 D Common Stock 2008-12-30 2008-12-30 4 S 0 5000 13.3691 D 4110 D Common Stock 2009-01-01 2009-01-01 5 J 0 700 11.6535 A 4810 D Employee Stock Option (right to buy) 12.9375 2008-12-30 2008-12-30 4 M 0 5000 0 D 2003-01-01 2008-12-31 Common Stock 5000 0 D Employee Stock Option (right to buy) 14.47 2009-01-02 2009-01-02 4 A 0 78229 0 A 2010-01-02 2016-01-01 Common Stock 78229 78229 D Acquired as a result of exercising a stock option that was scheduled to expire on 12/31/08. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/1/08. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/1/08. Reporting 700 shares acquired under the Isis Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan on January 1, 2009. Grant of 1-2-09 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 1-2-10. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 19,557 shares per year. The option is exercisable as to 0 shares on 1-2-09. /s/B. Lynne Parshall 2009-01-02 -----END PRIVACY-ENHANCED MESSAGE-----